|  | 24,500 people develop a blood cancer in the UK every year.
Blood cancers like leukaemia, lymphoma and myeloma affect people of all ages, from the very young to the very old. Tragically, these diseases are the most common cause of cancer deaths in children and in young people under the age of 35.
As the UK’s leading blood cancer research charity, our work touches the lives of the 110,000 people in the UK who are living with blood cancer. Each year, we commit more than £20 million to research and clinical trials at hospitals and universities all over the country.
Our research has four main goals:
 | to discover the causes of blood cancers |
| to understand how blood cells become cancerous |
| to refine diagnostic methods for the rapid and accurate assessment of these diseases |
| to devise new treatments for blood cancer patients and improve their quality of life. |
Leukaemia Research is a member of the National Cancer Research Institute (NCRI) Board. The NCRI is a UK-wide partnership between the Government, charity and industry which promotes co-operation in cancer research for the benefit of patients, the public and the scientific community. NCRI partners are the largest funders of cancer research in the UK. For more information go to www.ncri.org.uk
|
| |
| |  Dr Mark Lowdell
Clinical trial testing groundbreaking new treatment for acute myeloid leukaemia successfully recruits the first patient at the Royal Free Hospital in London.
Read more about this story in Research news here.
| |
|
